The Pharma business model requires heavy investment (100-300million) in frequent failures. They may get some 'winners', like Ivermectin, but in general it's a low probability bet on the research. So it makes business sense to hype marginal gains and obfuscate potential problems while buying political help. A string of research failures i…
The Pharma business model requires heavy investment (100-300million) in frequent failures. They may get some 'winners', like Ivermectin, but in general it's a low probability bet on the research. So it makes business sense to hype marginal gains and obfuscate potential problems while buying political help. A string of research failures is unlikely to lead to an admission of business insolvency, the next product may be a winner. They are not going to fold a multibillion dollar company with a "We tried". The model is precarious thus the advertising and political payola.
The Pharma business model requires heavy investment (100-300million) in frequent failures. They may get some 'winners', like Ivermectin, but in general it's a low probability bet on the research. So it makes business sense to hype marginal gains and obfuscate potential problems while buying political help. A string of research failures is unlikely to lead to an admission of business insolvency, the next product may be a winner. They are not going to fold a multibillion dollar company with a "We tried". The model is precarious thus the advertising and political payola.
Good points, Savvy Southerner. Wow. l And I just dissed ya! I guess I am just a little bit prejudiced agin' the American South, sorry about that.